Hinge Health, Inc. (HNGE) stock: key figures, P/E, revenue and dividend
Information Technology · United States · ISIN US4333131039
Hinge Health, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 587.86 m USD |
| Gross profit | 468.22 m USD |
| Operating income | -546.37 m USD |
| EBIT | -527.26 m USD |
| Net income | -528.26 m USD |
| Diluted EPS – continuing operations | -7.77 USD |
Full history since 2022, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Hinge Health, Inc.
Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation. The company also provides personalized and automated MSK care through AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device. It primarily serves self-insured employers. The company was founded in 2012 and is headquartered in San Francisco, California.
More stocks
- Mango Excellent Media Co Ltd (300413.SZ)
- Schaeffler (SHA0.DE)
- Zhejiang Huafon Spandex Co Ltd (002064.SZ)
- BlueFocus Communication Group (300058.SZ)
- China Reinsurance (Group) Corp (1508.HK)
- Beijing Huafeng Test & Control Technology Co Ltd (688200.SS)
- Wanxiang Qianchao Co Ltd (000559.SZ)
- Ampol Ltd (ALD.AX)
- Hyundai Autoever Corp (307950.KS)
- TERAWULF INC. (WULF)
- FLUOR CORP (FLR)
- Rompetrol Rafi (RRC.RO)
Not investment advice. All data without warranty, price as of 28.10.2026. Details in the risk notice.